ClinicalTrials.gov
ClinicalTrials.gov Menu

TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00144417
Recruitment Status : Completed
First Posted : September 5, 2005
Last Update Posted : August 3, 2011
Sponsor:
Collaborators:
Global Alliance for TB Drug Development
Bayer
Information provided by:
Centers for Disease Control and Prevention